Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study

Once-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) may increase patient adherence to treatment but may also be associated with a higher risk of bleeding. In this study, we investigated the adherence to once- or twice-daily dosing of NOACs and the risk of bleeding in nonvalvula...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bosn J Basic Med Sci
Hlavní autoři: Emren, Sadık Volkan, Zoghi, Mehdi, Berilgen, Rida, Özdemir, İbrahim Halil, Çelik, Oğuzhan, Çetin, Nurullah, Enhoş, Asım, Köseoğlu, Cemal, Akyüz, Abdurrahman, Doğan, Volkan, Levent, Fatih, Dereli, Yüksel, Doğan, Tolga, Başaran, Özcan, Karaca, Ilgın, Karaca, Özkan, Otlu, Yılmaz Ömür, Özmen, Çağlar, Coşar, Selvi, Sümerkan, Mutlu, Gürsul, Erdal, İnci, Sinan, Onrat, Ersel, Ergene, Oktay
Médium: Artigo
Jazyk:Inglês
Vydáno: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5988538/
https://ncbi.nlm.nih.gov/pubmed/28968197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17305/bjbms.2017.2279
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky